This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: The Innovative Contributions of Takemi Nakayoshi
Introduction
Takemi Nakayoshi is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of antibiotic suppositories. His work has implications for both human and veterinary medicine, showcasing his commitment to improving health outcomes.
Latest Patents
Takemi Nakayoshi holds a patent for a method of producing aminoglycoside antibiotics in the form of suppositories. This innovative method involves dispersing an aminoglycoside antibiotic substance or its non-toxic salts in an oleaginous or aqueous base. The process includes the addition of at least a nonionic surface-active agent and/or an anionic surface-active agent. The result is a pharmaceutically safe and effective suppository suitable for use in living animals and humans, including infants.
Career Highlights
Throughout his career, Nakayoshi has been associated with Meiji Seika Kaisha, Ltd., a company known for its advancements in the pharmaceutical industry. His work has not only contributed to the company's reputation but has also paved the way for new treatment options in antibiotic therapy.
Collaborations
Takemi Nakayoshi has collaborated with esteemed colleagues such as Kaoru Hosoi and Tadamasa Ikeda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Takemi Nakayoshi's contributions to the field of pharmaceuticals, particularly through his patented method for producing antibiotic suppositories, highlight his role as an influential inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
